



Market Maker Surveillance Report. SENS, AEZS, CERS, LWLG, GLBS, ZSAN, Winning Stocks With Lowest Price Friction For Friday, Ma
May 26, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5539 companies with "abnormal" market making, 2815 companies with positive Friction Factors and 2782 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Friday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Senseonics Holdings Inc. (NYSE:SENS), AEterna Zentaris Inc. (NASDAQ:AEZS), Cerus Corporation (NASDAQ:CERS), LIGHTWAVE LOGIC Inc. (OTC:LWLG), Globus Mrtm (NASDAQ:GLBS), Zosano Pharma (NASDAQ:ZSAN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction SENS $0.250 0.18% 535,650 42.22% 469,925 37.04% 65,725 2,629 AEZS $0.220 0.23% 1,158,368 40.77% 1,020,141 35.90% 138,227 6,283 CERS $0.330 0.16% 1,210,281 45.19% 977,682 36.50% 232,599 7,048 LWLG $0.170 0.12% 342,118 75.83% 108,625 24.08% 233,493 13,735 GLBS $0.140 0.11% 835,900 43.17% 830,009 42.87% 5,891 421 ZSAN $0.160 0.12% 1,348,955 40.69% 1,265,116 38.16% 83,839 5,240Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows SENS with a dollar gain Friday of $0.25000 and a Friction Factor of 2,629 shares. That means that it only took 2,629 more shares of buying than selling to move SENS higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
Senseonics Holdings Inc. (NYSE:SENS) - Sentex Sensing Technology, Inc. (Sentex) previously operated through its wholly owned subsidiary, Regency Technologies, LLC. (Regency). Regency, which was acquired by the Company in July 2001, specializes in the buying, selling and trading of information technology equipment (primarily computer equipment). The primary focus of its business revolves around acquiring unneeded, older computer equipment and reselling that equipment to certain consumers on a global basis.
On November 20, 2005, Sentex entered into a Contribution and Investment Agreement (the Investment Agreement) with JJJ-RT, LLC, Regency and Regency Acquisition, LLC (New LLC), a wholly owned subsidiary of Regency. Under the Investment Agreement, Regency contributed all of its operating assets to New LLC and New LLC assumed all of the obligations of Regency and certain inter-company accounts payable between Regency and the Company. JJJ-RT, on the other hand, obtained the right to invest up to $800,000 in New LLC on an as-needed basis. The members of JJJ-RT primarily control when any such investments are made. For every $10,000 of capital JJJ-RT invests into New LLC, JJJ-RT is entitled to 1% of the equity interest until it owns 50% of the interests of New LLC. These investments by JJJ-RT dilute the Company's interests in New LLC.
As a result of these arrangements and with the understanding that it is the intention of JJJ-RT to obtain a majority position prior to the end of the next fiscal year, the Company, together in consultation with its outside auditors, has concluded that JJJ-RT should be the consolidating entity. Accordingly, the Company has not reflected the assets, liabilities, revenue or expenses of the New LLC in its financial statements. As such, the Company has not provided a discussion of New LLC operations or liquidity and capital resources..
AEterna Zentaris Inc. (NASDAQ:AEZS) - Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. The company s product pipeline includes Zoptrex, which completed Phase III clinical study for women with advanced, recurrent, or metastatic endometrial cancer, as well as in various phases for the treatment of ovarian and prostate cancer; and MACRILEN, which completed Phase III trial for use in the diagnosis of adult growth hormone deficiency. It is also developing an LHRH-disorazol Z conjugate, which is in pre-clinical development in oncology. Aeterna Zentaris Inc. was founded in 1991 and is headquartered in Summerville, South Carolina..
Cerus Corporation (NASDAQ:CERS) - Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. The company s INTERCEPT Blood Systems for platelets and plasma are designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion. It markets platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was founded in 1991 and is headquartered in Concord, California..
LIGHTWAVE LOGIC Inc. (OTC:LWLG) - Lightwave Logic, Inc. operates as a development stage, electro-optical device and organic nonlinear materials company. It develops organic application specific electro-optic polymers and organic non-linear all-optical polymers that have high electro-optic and optical activity. The company intends to sells its products to electro-optic device manufacturers, such as telecommunications component and systems manufacturers, networking and switching suppliers, semiconductor companies, aerospace companies, government agencies, and internal device development. Lightwave Logic, Inc. has strategic partnership with Boulder Nonlinear Systems, Inc. The company was formerly known as Third-order Nanotechnologies, Inc. and changed its name to Lightwave Logic, Inc. in March 2008. Lightwave Logic, Inc. was founded in 1991 and is headquartered in Longmont, Colorado..
Globus Mrtm (NASDAQ:GLBS) - Globus Maritime Limited, an integrated dry bulk shipping company, provides marine transportation services worldwide. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargoes. As of March 31, 2016, its fleet comprised a total of five dry bulk vessels consisting of one Panamax and four Supramaxes. The company was founded in 2006 and is based in Athens, Greece. Globus Maritime Limited operates as a subsidiary of Firment Trading Limited..
Zosano Pharma (NASDAQ:ZSAN) - .
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net